| Title |
Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine
|
|---|---|
| Published in |
Psychopharmacology, November 2013
|
| DOI | 10.1007/s00213-013-3343-y |
| Pubmed ID | |
| Authors |
Josep Antoni Ramos-Quiroga, Margarida Corominas-Roso, Gloria Palomar, Nuria Gomez-Barros, Marta Ribases, Cristina Sanchez-Mora, Rosa Bosch, Mariana Nogueira, Montserrat Corrales, Sergi Valero, Miguel Casas |
| Abstract |
Atomoxetine (ATX) is a non-stimulant drug approved for the treatment of attention deficit hyperactivity disorder (ADHD). Although animal models have provided evidence that brain-derived neurotrophic factor (BDNF) is involved in the effects of ATX in the brain, there are no studies of BDNF in ADHD patients undergoing treatment with ATX. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 40% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 2% |
| Unknown | 57 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 24% |
| Researcher | 8 | 14% |
| Student > Ph. D. Student | 5 | 9% |
| Student > Bachelor | 4 | 7% |
| Student > Doctoral Student | 4 | 7% |
| Other | 8 | 14% |
| Unknown | 15 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 14 | 24% |
| Medicine and Dentistry | 9 | 16% |
| Business, Management and Accounting | 4 | 7% |
| Neuroscience | 4 | 7% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 8 | 14% |
| Unknown | 17 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2015.
All research outputs
#13,094,702
of 23,613,071 outputs
Outputs from Psychopharmacology
#3,877
of 5,418 outputs
Outputs of similar age
#108,301
of 217,441 outputs
Outputs of similar age from Psychopharmacology
#27
of 52 outputs
Altmetric has tracked 23,613,071 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,418 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,441 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.